REFERENCES
1. Wong SC, Zacharin M. Long-term health outcomes of adults with
McCune-Albright syndrome. Clin Endocrinol (Oxf). 2017;87(5):627-34.
2. Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare
Dis. 2008;3:12.
3. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, et al.
Natural history and treatment of fibrous dysplasia of bone: a
multicenter clinicopathologic study promoted by the European Pediatric
Orthopaedic Society. J Pediatr Orthop B. 2003;12(3):155-77.
4. Volkl TM, Dorr HG. McCune-Albright syndrome: clinical picture and
natural history in children and adolescents. J Pediatr Endocrinol Metab.
2006;19 Suppl 2:551-9.
5. Narumi S, Matsuo K, Ishii T, Tanahashi Y, Hasegawa T. Quantitative
and sensitive detection of GNAS mutations causing mccune-albright
syndrome with next generation sequencing. PloS one. 2013;8(3):e60525.
6. Cho EK, Kim J, Yang A, Ki CS, Lee JE, Cho SY, et al. Clinical and
endocrine characteristics and genetic analysis of Korean children with
McCune-Albright syndrome: a retrospective cohort study. Orphanet J Rare
Dis. 2016;11(1):113.
7. Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, et al. Acute
heart failure. Nat Rev Dis Primers. 2020;6(1):16.
8. MacMahon HE. Albright’s syndrome–thirty years later. (Polyostotic
fibrous dysplasia). Pathology annual. 1971;6:81-146.
9. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM,
et al. Severe endocrine and nonendocrine manifestations of the
McCune-Albright syndrome associated with activating mutations of
stimulatory G protein GS. J Pediatr. 1993;123(4):509-18.
10. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase
inhibiting mutations activate the alpha chain of Gs and stimulate
adenylyl cyclase in human pituitary tumours. Nature.
1989;340(6236):692-6.
11. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel
AM. Activating mutations of the stimulatory G protein in the
McCune-Albright syndrome. The New England journal of medicine.
1991;325(24):1688-95.
12. Schwindinger WF, Francomano CA, Levine MA. Identification of a
mutation in the gene encoding the alpha subunit of the stimulatory G
protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad
Sci U S A. 1992;89(11):5152-6.
13. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD,
Malchoff DM. An unusual presentation of McCune-Albright syndrome
confirmed by an activating mutation of the Gs alpha-subunit from a bone
lesion. J Clin Endocrinol Metab. 1994;78(3):803-6.
14. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT,
Mankani MH, et al. Mutations of the GNAS1 gene, stromal cell
dysfunction, and osteomalacic changes in non-McCune-Albright fibrous
dysplasia of bone. J Bone Miner Res. 2000;15(1):120-8.
15. Hart ES, Kelly MH, Brillante B, Chen CC, Ziran N, Lee JS, et al.
Onset, progression, and plateau of skeletal lesions in fibrous dysplasia
and the relationship to functional outcome. J Bone Miner Res.
2007;22(9):1468-74.
16. Collins MT. Spectrum and natural history of fibrous dysplasia of
bone. J Bone Miner Res. 2006;21 Suppl 2:P99-P104.
17. Mittal R, Martin RP. Cardiac failure associated with McCune-Albright
syndrome. Br J Hosp Med (Lond). 2015;76(10):604-5.
18. Baggish AL, Siebert U, Lainchbury JG, Cameron R, Anwaruddin S, Chen
A, et al. A validated clinical and biochemical score for the diagnosis
of acute heart failure: the ProBNP Investigation of Dyspnea in the
Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J.
2006;151(1):48-54.
19. Heart Failure Society of A, Lindenfeld J, Albert NM, Boehmer JP,
Collins SP, Ezekowitz JA, et al. HFSA 2010 Comprehensive Heart Failure
Practice Guideline. J Card Fail. 2010;16(6):e1-194.
20. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis
SM, et al. Effect of oral milrinone on mortality in severe chronic heart
failure. The PROMISE Study Research Group. The New England journal of
medicine. 1991;325(21):1468-75.
21. Bockus LB, Humphries KM. cAMP-dependent Protein Kinase (PKA)
Signaling Is Impaired in the Diabetic Heart. The Journal of biological
chemistry. 2015;290(49):29250-8.
22. Ai L, Perez E, Asimes A, Kampaengsri T, Heroux M, Zlobin A, et al.
Binge Alcohol Exposure in Adolescence Impairs Normal Heart Growth.
Journal of the American Heart Association. 2020;9(9):e015611.
23. Demers C, Rouleau JL, Leung TK, Tardif JC. Hypercalcemic
cardiomyopathy associated with primary hyperparathyroidism mimicking
primary obstructive hypertrophic cardiomyopathy. Can J Cardiol.
1998;14(11):1397-400.